Advertisement

Index by author

March 01, 2005; Volume 33,Issue 3

A

  1. Akiyama, Taro E.

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

  2. André, F.

    1. CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097

  3. Annaert, Pieter P.

    1. ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES
      Pieter P. Annaert and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2005, 33 (3) 388-394; DOI: https://doi.org/10.1124/dmd.104.001669

  4. Austin, Rupert P.

    1. THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436

B

  1. Barton, Patrick

    1. THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436

  2. Bessette, Erin E.

    1. MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212

  3. Brouwer, Kim L. R.

    1. ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES
      Pieter P. Annaert and Kim L. R. Brouwer
      Drug Metabolism and Disposition March 2005, 33 (3) 388-394; DOI: https://doi.org/10.1124/dmd.104.001669

  4. Buratti, Franca M.

    1. MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

C

  1. Chaudhary, Ashok

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
    2. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915

  2. Chen, Mei-Ling

    1. DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

  3. Cheung, Connie

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

  4. Chung, Suk-Jae

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

  5. Coburn, Robert A.

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

D

  1. D'Aniello, Alessandra

    1. MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

  2. Dale, Ola

    1. METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709

  3. Delaforge, M.

    1. CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097

  4. Di Marco, Annalise

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915

E

  1. Ekins, Sean

    1. A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717

  2. El-Kadi, Ayman O. S.

    1. tert-BUTYLHYDROQUINONE IS A NOVEL ARYL HYDROCARBON RECEPTOR LIGAND
      Negar Gharavi and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition March 2005, 33 (3) 365-372; DOI: https://doi.org/10.1124/dmd.104.002253

F

  1. Fasco, Michael J.

    1. MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212

  2. Feigenbaum, Lionel

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

G

  1. Gaman, Emily A.

    1. SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766

  2. Gharavi, Negar

    1. tert-BUTYLHYDROQUINONE IS A NOVEL ARYL HYDROCARBON RECEPTOR LIGAND
      Negar Gharavi and Ayman O. S. El-Kadi
      Drug Metabolism and Disposition March 2005, 33 (3) 365-372; DOI: https://doi.org/10.1124/dmd.104.002253

  3. Gleeson, Jean-Paul R.

    1. SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766

  4. Gonzalez, Frank J.

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

H

  1. Haraguchi, Koichi

    1. COMPARATIVE METABOLISM OF POLYCHLORINATED BIPHENYLS AND TISSUE DISTRIBUTION OF PERSISTENT METABOLITES IN RATS, HAMSTERS, AND GUINEA PIGS
      Koichi Haraguchi, Nobuyuki Koga and Yoshihisa Kato
      Drug Metabolism and Disposition March 2005, 33 (3) 373-380; DOI: https://doi.org/10.1124/dmd.104.002444

  2. Hasegawa, Ryuichi

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  3. He, Xiao-Yang

    1. HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
      Shou-Lin Wang, Xiao-Yang He and Jun-Yan Hong
      Drug Metabolism and Disposition March 2005, 33 (3) 336-340; DOI: https://doi.org/10.1124/dmd.104.002923

  4. Hirao, Yukihiro

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

  5. Ho, Shung-Tai

    1. IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451

  6. Hong, Jun-Yan

    1. HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
      Shou-Lin Wang, Xiao-Yang He and Jun-Yan Hong
      Drug Metabolism and Disposition March 2005, 33 (3) 336-340; DOI: https://doi.org/10.1124/dmd.104.002923

  7. Hsiong, Cheng-Huei

    1. IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451

  8. Hu, Oliver Yoa-Pu

    1. IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451

  9. Huang, Shiew-Mei

    1. DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

I

  1. Inada, Makoto

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

  2. Itose, Minoru

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

J

  1. Jinno, Hideto

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

K

  1. Kaji, Hidefumi

    1. REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM
      Hidefumi Kaji and Toshiyuki Kume
      Drug Metabolism and Disposition March 2005, 33 (3) 403-412; DOI: https://doi.org/10.1124/dmd.104.002667

  2. Kaminsky, Laurence S.

    1. MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212

  3. Kaniwa, Nahoko

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  4. Kato, Yoshihisa

    1. COMPARATIVE METABOLISM OF POLYCHLORINATED BIPHENYLS AND TISSUE DISTRIBUTION OF PERSISTENT METABOLITES IN RATS, HAMSTERS, AND GUINEA PIGS
      Koichi Haraguchi, Nobuyuki Koga and Yoshihisa Kato
      Drug Metabolism and Disposition March 2005, 33 (3) 373-380; DOI: https://doi.org/10.1124/dmd.104.002444

  5. Kharasch, Evan D.

    1. METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709

  6. Kim, Dae-Duk

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

  7. Kirillov, Eugene

    1. A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717

  8. Klees, Theresa Mariero

    1. METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709

  9. Koga, Nobuyuki

    1. COMPARATIVE METABOLISM OF POLYCHLORINATED BIPHENYLS AND TISSUE DISTRIBUTION OF PERSISTENT METABOLITES IN RATS, HAMSTERS, AND GUINEA PIGS
      Koichi Haraguchi, Nobuyuki Koga and Yoshihisa Kato
      Drug Metabolism and Disposition March 2005, 33 (3) 373-380; DOI: https://doi.org/10.1124/dmd.104.002444

  10. Koga, Toshihisa

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

  11. Krausz, Kristopher W.

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

  12. Kume, Toshiyuki

    1. REGIOSELECTIVE GLUCURONIDATION OF DENOPAMINE: MARKED SPECIES DIFFERENCES AND IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ISOFORM
      Hidefumi Kaji and Toshiyuki Kume
      Drug Metabolism and Disposition March 2005, 33 (3) 403-412; DOI: https://doi.org/10.1124/dmd.104.002667

  13. Kunizaki, Jun-ichi

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

  14. Kurose, Kouichi

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

L

  1. Laufer, Ralph

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
    2. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915

  2. Ludington, Shana S.

    1. DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

M

  1. Marco, Annalise Di

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873

  2. Marcucci, Isabella

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873
    2. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915

  3. Meneguz, Annarita

    1. MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

  4. Minami, Hironobu

    1. ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909

  5. Mohmed, Sarfraz

    1. THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436

  6. Morris, Marilyn E.

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
    2. FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501

N

  1. Nikolskaya, Tatiana

    1. A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717

  2. Nozawa, Takashi

    1. ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909

O

  1. Obach, R. Scott

    1. SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766

  2. Ou, Junhai

    1. PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287

P

  1. Paine, Mary F.

    1. DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

  2. Pao, Li-Heng

    1. IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451

  3. Park, Jin-Sun

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

  4. Peláez, Fernando

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873

  5. Pentecost, Brian T.

    1. MECHANISMS OF ARSENITE-MEDIATED DECREASES IN BENZO[K]FLUORANTHENE-INDUCED HUMAN CYTOCHROME P4501A1 LEVELS IN HEPG2 CELLS
      Erin E. Bessette, Michael J. Fasco, Brian T. Pentecost and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2005, 33 (3) 312-320; DOI: https://doi.org/10.1124/dmd.104.002212

  6. Pérez, José

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873

  7. Perrin, L.

    1. CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097

  8. Proctor, William R.

    1. SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766

  9. Pruvost, A.

    1. CYTOCHROME P450-MEDIATED OXIDATION OF GLUCURONIDE DERIVATIVES: EXAMPLE OF ESTRADIOL-17β-GLUCURONIDE OXIDATION TO 2-HYDROXY-ESTRADIOL-17β-GLUCURONIDE BY CYP 2C8
      M. Delaforge, A. Pruvost, L. Perrin and F. André
      Drug Metabolism and Disposition March 2005, 33 (3) 466-473; DOI: https://doi.org/10.1124/dmd.104.002097

R

  1. Rakhmatulin, Eugene A.

    1. A NOVEL METHOD FOR VISUALIZING NUCLEAR HORMONE RECEPTOR NETWORKS RELEVANT TO DRUG METABOLISM
      Sean Ekins, Eugene Kirillov, Eugene A. Rakhmatulin and Tatiana Nikolskaya
      Drug Metabolism and Disposition March 2005, 33 (3) 474-481; DOI: https://doi.org/10.1124/dmd.104.002717

  2. Riley, Robert J.

    1. THE BINDING OF DRUGS TO HEPATOCYTES AND ITS RELATIONSHIP TO PHYSICOCHEMICAL PROPERTIES
      Rupert P. Austin, Patrick Barton, Sarfraz Mohmed and Robert J. Riley
      Drug Metabolism and Disposition March 2005, 33 (3) 419-425; DOI: https://doi.org/10.1124/dmd.104.002436

S

  1. Saeki, Mayumi

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  2. Sagawa, Kazuko

    1. FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501

  3. Saito, Yoshiro

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  4. Sanchez, Manuel

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873

  5. Sato, Hitoshi

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

  6. Sawada, Jun-ichi

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  7. Schentag, Jerome J.

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

  8. Scott-Ramsay, Elizabeth

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

  9. Sheffels, Pamela

    1. METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMES
      Theresa Mariero Klees, Pamela Sheffels, Ola Dale and Evan D. Kharasch
      Drug Metabolism and Disposition March 2005, 33 (3) 303-311; DOI: https://doi.org/10.1124/dmd.104.002709

  10. Shim, Chang-Koo

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

  11. Shimizu, Takefumi

    1. RELATIONSHIPS AMONG PLASMA [2-13C]URACIL CONCENTRATIONS, BREATH 13CO2 EXPIRATION, AND DIHYDROPYRIMIDINE DEHYDROGENASE (DPD) ACTIVITY IN THE LIVER IN NORMAL AND DPD-DEFICIENT DOGS
      Makoto Inada, Yukihiro Hirao, Toshihisa Koga, Minoru Itose, Jun-ichi Kunizaki, Takefumi Shimizu and Hitoshi Sato
      Drug Metabolism and Disposition March 2005, 33 (3) 381-387; DOI: https://doi.org/10.1124/dmd.104.001032

  12. Stewart, Paul W.

    1. DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

  13. Strom, Stephen C.

    1. PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287

  14. Sugiura, Shigeki

    1. ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909

  15. Sung, Jong-Hyuk

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

T

  1. Taliani, Marina

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP2C9 INHIBITION ASSAY USING TRITIATED DICLOFENAC
      Annalise Di Marco, Isabella Marcucci, Ashok Chaudhary, Marina Taliani and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 359-364; DOI: https://doi.org/10.1124/dmd.104.002915

  2. Tamai, Ikumi

    1. ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909

  3. Tanaka-Kagawa, Toshiko

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  4. Testai, Emanuela

    1. MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

  5. Tian, Hui

    1. PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287

  6. Tohkin, Masahiro

    1. RACIAL VARIABILITY IN HAPLOTYPE FREQUENCIES OF UGT1A1 AND GLUCURONIDATION ACTIVITY OF A NOVEL SINGLE NUCLEOTIDE POLYMORPHISM 686C> T (P229L) FOUND IN AN AFRICAN-AMERICAN
      Nahoko Kaniwa, Kouichi Kurose, Hideto Jinno, Toshiko Tanaka-Kagawa, Yoshiro Saito, Mayumi Saeki, Jun-ichi Sawada, Masahiro Tohkin and Ryuichi Hasegawa
      Drug Metabolism and Disposition March 2005, 33 (3) 458-465; DOI: https://doi.org/10.1124/dmd.104.001800

  7. Tseng, Elaine

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

  8. Tsuji, Akira

    1. ROLE OF ORGANIC ANION TRANSPORTER OATP1B1 (OATP-C) IN HEPATIC UPTAKE OF IRINOTECAN AND ITS ACTIVE METABOLITE, 7-ETHYL-10-HYDROXYCAMPTOTHECIN: IN VITRO EVIDENCE AND EFFECT OF SINGLE NUCLEOTIDE POLYMORPHISMS
      Takashi Nozawa, Hironobu Minami, Shigeki Sugiura, Akira Tsuji and Ikumi Tamai
      Drug Metabolism and Disposition March 2005, 33 (3) 434-439; DOI: https://doi.org/10.1124/dmd.104.001909

  9. Tsuruo, Takashi

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

V

  1. Venkataramanan, Raman

    1. PHARMACOKINETICS OF TACROLIMUS AND MYCOPHENOLIC ACID ARE ALTERED, BUT RECOVER AT DIFFERENT TIMES DURING HEPATIC REGENERATION IN RATS
      Hui Tian, Junhai Ou, Stephen C. Strom and Raman Venkataramanan
      Drug Metabolism and Disposition March 2005, 33 (3) 329-335; DOI: https://doi.org/10.1124/dmd.104.002287

  2. Verdirame, Maria

    1. DEVELOPMENT AND VALIDATION OF A HIGH-THROUGHPUT RADIOMETRIC CYP3A4/5 INHIBITION ASSAY USING TRITIATED TESTOSTERONE
      Annalise Di Marco, Isabella Marcucci, Maria Verdirame, José Pérez, Manuel Sanchez, Fernando Peláez, Ashok Chaudhary and Ralph Laufer
      Drug Metabolism and Disposition March 2005, 33 (3) 349-358; DOI: https://doi.org/10.1124/dmd.104.002873

  3. Volpe, Maria Teresa

    1. MALATHION BIOACTIVATION IN THE HUMAN LIVER: THE CONTRIBUTION OF DIFFERENT CYTOCHROME P450 ISOFORMS
      Franca M. Buratti, Alessandra D'Aniello, Maria Teresa Volpe, Annarita Meneguz and Emanuela Testai
      Drug Metabolism and Disposition March 2005, 33 (3) 295-302; DOI: https://doi.org/10.1124/dmd.104.001693

W

  1. Walsky, Robert L.

    1. SELECTIVE INHIBITION OF HUMAN CYTOCHROME P4502C8 BY MONTELUKAST
      Robert L. Walsky, R. Scott Obach, Emily A. Gaman, Jean-Paul R. Gleeson and William R. Proctor
      Drug Metabolism and Disposition March 2005, 33 (3) 413-418; DOI: https://doi.org/10.1124/dmd.104.002766

  2. Wang, Jhi-Jung

    1. IN VITRO AND IN VIVO EVALUATION OF THE METABOLISM AND PHARMACOKINETICS OF SEBACOYL DINALBUPHINE
      Li-Heng Pao, Cheng-Huei Hsiong, Oliver Yoa-Pu Hu, Jhi-Jung Wang and Shung-Tai Ho
      Drug Metabolism and Disposition March 2005, 33 (3) 395-402; DOI: https://doi.org/10.1124/dmd.104.002451

  3. Wang, Shou-Lin

    1. HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE
      Shou-Lin Wang, Xiao-Yang He and Jun-Yan Hong
      Drug Metabolism and Disposition March 2005, 33 (3) 336-340; DOI: https://doi.org/10.1124/dmd.104.002923

  4. Wang, Xiaodong

    1. FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501

  5. Ward, Jerrold M.

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

  6. Watkins, Paul B.

    1. DO MEN AND WOMEN DIFFER IN PROXIMAL SMALL INTESTINAL CYP3A OR P-GLYCOPROTEIN EXPRESSION?
      Mary F. Paine, Shana S. Ludington, Mei-Ling Chen, Paul W. Stewart, Shiew-Mei Huang and Paul B. Watkins
      Drug Metabolism and Disposition March 2005, 33 (3) 426-433; DOI: https://doi.org/10.1124/dmd.104.002469

Y

  1. Yu, Ai-Ming

    1. THE CYP2E1-HUMANIZED TRANSGENIC MOUSE: ROLE OF CYP2E1 IN ACETAMINOPHEN HEPATOTOXICITY
      Connie Cheung, Ai-Ming Yu, Jerrold M. Ward, Kristopher W. Krausz, Taro E. Akiyama, Lionel Feigenbaum and Frank J. Gonzalez
      Drug Metabolism and Disposition March 2005, 33 (3) 449-457; DOI: https://doi.org/10.1124/dmd.104.002402

  2. Yu, Kyung-Ha

    1. SATURABLE DISTRIBUTION OF TACRINE INTO THE STRIATAL EXTRACELLULAR FLUID OF THE RAT: EVIDENCE OF INVOLVEMENT OF MULTIPLE ORGANIC CATION TRANSPORTERS IN THE TRANSPORT
      Jong-Hyuk Sung, Kyung-Ha Yu, Jin-Sun Park, Takashi Tsuruo, Dae-Duk Kim, Chang-Koo Shim and Suk-Jae Chung
      Drug Metabolism and Disposition March 2005, 33 (3) 440-448; DOI: https://doi.org/10.1124/dmd.104.002220

Z

  1. Zhang, Linping

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089

  2. Zhang, Shuzhong

    1. FLAVONOIDS CHRYSIN AND BENZOFLAVONE, POTENT BREAST CANCER RESISTANCE PROTEIN INHIBITORS, HAVE NO SIGNIFICANT EFFECT ON TOPOTECAN PHARMACOKINETICS IN RATS OR MDR1A/1B (–/–) MICE
      Shuzhong Zhang, Xiaodong Wang, Kazuko Sagawa and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 341-348; DOI: https://doi.org/10.1124/dmd.104.002501

  3. Zhou, Xiao-fei

    1. NEW 4-ARYL-1,4-DIHYDROPYRIDINES AND 4-ARYLPYRIDINES AS P-GLYCOPROTEIN INHIBITORS
      Xiao-fei Zhou, Linping Zhang, Elaine Tseng, Elizabeth Scott-Ramsay, Jerome J. Schentag, Robert A. Coburn and Marilyn E. Morris
      Drug Metabolism and Disposition March 2005, 33 (3) 321-328; DOI: https://doi.org/10.1124/dmd.104.002089
Back to top

In this issue